Nuvectis Pharma Inc. (NVCT)

AI Score

Unlock

8.87

0.17 (1.95%)

At close: Apr 17, 2025, 3:59 PM

9.18

3.51%

After-hours: Apr 17, 2025, 04:49 PM EDT

Nuvectis Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Net Income	-19M	-19.37M	-21.1M	-22.38M	-22.26M	-22.33M	-22.33M	-20.19M	-19.09M	-14.65M	-13.44M	-15.81M	-12.89M	-10.63M	-5.96M	-23K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.12M	1.2M	4.91M	4.6M	4.71M	3.97M	3.39M	2.95M	1.71M	1.41M	987K	2.05M	1.89M	1.71M	1.57M	n/a
Other Working Capital	2.92M	2.04M	2.62M	3.24M	1.58M	2.75M	1.24M	1.08M	2.38M	-785.56K	-679K	-839K	-8K	462K	356K	n/a
Other Non-Cash Items	6.48M	7.68M	5.82M	5.59M	4.68M	3.97M	2.84M	2.4M	1.15M	852.51K	987K	2.05M	1.92M	1.73M	1.59M	23K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.64M	1.55M	1.72M	2.25M	1.6M	2.75M	2.14M	1.98M	3.82M	2.13M	1.34M	1.18M	1.49M	485K	379K	23K
Operating Cash Flow	-12.25M	-13.63M	-14.47M	-15.54M	-15.95M	-15.62M	-16.8M	-15.26M	-13.56M	-11.11M	-11.11M	-12.58M	-9.5M	-8.44M	-4.01M	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-382K	-242K	-615K	9.39M	9.8M	9.65M	8.69M	-1.84M	-4.07M	-3.94M	-2.55M	9.25M	11.22M	11.22M	11.22M	n/a
Financial Cash Flow	11.65M	8.74M	7.99M	19.53M	15.09M	14.04M	27.83M	14.04M	27.81M	27.94M	17.47M	29.27M	15.25M	15.25M	11.22M	n/a
Net Cash Flow	-593K	-4.89M	-6.48M	4M	-867K	-1.58M	11.03M	-1.23M	14.25M	16.83M	6.36M	16.69M	5.74M	6.81M	7.21M	n/a
Free Cash Flow	-12.25M	-13.63M	-14.47M	-15.54M	-15.95M	-15.62M	-16.8M	-15.26M	-13.56M	-11.11M	-11.11M	-12.58M	-9.5M	-8.44M	-4.01M	n/a